Iguratimod Modulates M1 Macrophage Polarization Via the NOTCH4–KLF4 Axis to Alleviate Antibody-Mediated Rejection
Frontiers in Bioscience-Landmark · 30.09.2026 · 31 (10)
DOI: 10.31083/fbl54785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 30.09.2026. Verfasst von Zhou Hang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical Unive…. Hauptthemen laut MEDLINE: Macrophages, Receptor, Notch4, Graft Rejection, Sulfonamides. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Province Natural Science Foundation Program.
Abstract (Originalsprache)
Background
Iguratimod (IGT) is a small-molecule anti-inflammatory agent that effectively attenuates the progression of antibody-mediated rejection (ABMR). However, the underlying mechanism of action of IGT remains poorly understood. Thus, this study aimed to investigate the mechanism through which IGT regulates macrophage polarization and ABMR.
Methods
A mouse model of ABMR was established by performing kidney transplantation after skin graft-induced sensitization. Experimental interventions included neurogenic locus notch homolog protein 4 (NOTCH4) knockout mice and oral administration of IGT. RNA sequencing, quantitative polymerase chain reaction, Western blotting (WB), flow cytometry, and immunofluorescence (IF) staining were performed to investigate M1 macrophage polarization and the Jagged1–NOTCH4 signaling pathway.
Results
This study found that IGT significantly reduced M1 macrophage infiltration into renal allografts in a mouse model of ABMR. Transcriptomic sequencing and subsequent biological experiments indicated that IGT may regulate macrophage polarization through the Jagged1–NOTCH4 pathway.
Conclusion
M1 macrophage polarization may contribute to the initiation and progression of ABMR following kidney transplantation. IGT attenuates M1 macrophage polarization by inhibiting Jagged1–NOTCH4–Krüppel-like Factor 4 (KLF4) signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 210008 Nanjing, Jiangsu, China.
- Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 210008 Nanjing, Jiangsu, China.
Förderung
- National Natural Science Foundation of China
- Jiangsu Province Natural Science Foundation Program
Zitieren
APA
Hang, Z., Zhang, J., Yang, C., Zheng, M., Yang, Z., Xu, J., Han, P., & Gu, M. (2026). Iguratimod Modulates M1 Macrophage Polarization Via the NOTCH4–KLF4 Axis to Alleviate Antibody-Mediated Rejection. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl54785
Vancouver
Hang Z, Zhang J, Yang C, Zheng M, Yang Z, Xu J, et al. Iguratimod Modulates M1 Macrophage Polarization Via the NOTCH4–KLF4 Axis to Alleviate Antibody-Mediated Rejection. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl54785
BibTeX
@article{Hang2026,
author = {Hang, Zhou and Zhang, Junqi and Yang, Chengcheng and Zheng, Ming and Yang, Zexin and Xu, Jie and Han, Peng and Gu, Min},
title = {Iguratimod Modulates M1 Macrophage Polarization Via the NOTCH4–KLF4 Axis to Alleviate Antibody-Mediated Rejection},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {10},
doi = {10.31083/fbl54785}
}
EUVIMED